• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.

作者信息

Kiss Norbert, Lőrincz Kende, Medvecz Márta, Fésűs Luca, Csuha Péter, Hermányi Zsolt, Wikonkál Norbert Miklós

机构信息

Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.

3rd Department of Internal Medicine, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.

出版信息

Dermatol Ther. 2020 Nov;33(6):e14186. doi: 10.1111/dth.14186. Epub 2020 Sep 8.

DOI:10.1111/dth.14186
PMID:32794375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7441282/
Abstract
摘要

相似文献

1
Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.一名正在接受司库奇尤单抗治疗的银屑病患者合并慢性阻塞性肺疾病，感染新型冠状病毒肺炎2019。
Dermatol Ther. 2020 Nov;33(6):e14186. doi: 10.1111/dth.14186. Epub 2020 Sep 8.
2
COVID-19 Updates: Monoclonal Antibodies for COVID-19.新冠疫情最新消息：用于治疗新冠的单克隆抗体
Med Lett Drugs Ther. 2022 Jan 24;64(1642):16.
3
Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?司库奇尤单抗治疗的银屑病患者发生2019冠状病毒病（COVID-19）皮疹：白细胞介素17起作用吗？
Dermatol Ther. 2020 Nov;33(6):e14011. doi: 10.1111/dth.14011. Epub 2020 Jul 27.
4
Alopecia areata in a patient with SARS-Cov-2 infection.一名感染新型冠状病毒肺炎（SARS-CoV-2）的患者出现斑秃。
Dermatol Ther. 2020 Nov;33(6):e14295. doi: 10.1111/dth.14295. Epub 2020 Sep 21.
5
[Final recommendations to incorporate efalizumab into the clinical practice].
Actas Dermosifiliogr. 2008 Jan;99 Suppl 1:82. doi: 10.1016/s0001-7310(08)76202-1.
6
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.老年银屑病患者的抗白细胞介素-23 治疗：真实世界中 Guselkumab、Risankizumab 和 Tildrakizumab 的应用。
Clin Exp Dermatol. 2022 Mar;47(3):561-567. doi: 10.1111/ced.14979. Epub 2021 Nov 17.
7
Biologicals in the treatment of psoriasis.生物制剂在银屑病治疗中的应用
Curr Opin Investig Drugs. 2007 Nov;8(11):939-46.
8
Guselkumab (Tremfya) for psoriasis.古塞库单抗（特诺雅）用于治疗银屑病。
Med Lett Drugs Ther. 2017 Nov 6;59(1533):179-180.
9
Broadalumab (Siliq)--another IL-17A antagonist for psoriasis.布罗达单抗（Siliq）——另一种用于治疗银屑病的白细胞介素-17A拮抗剂。
Med Lett Drugs Ther. 2017 Jul 17;59(1525):118-119.
10
Depression? It's the Disease NOT the Drug.抑郁症？患病的是疾病而非药物。
J Drugs Dermatol. 2018 Aug 1;17(8):s28.

引用本文的文献

1
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.经受住风暴：年龄和生物制剂如何影响COVID-19细胞因子风暴
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
2
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.新冠病毒的免疫特征：细胞因子风暴的深入原因及后果。
Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545.
3
Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.银屑病红皮病型发作合并新型冠状病毒肺炎感染：两例报告及文献综述，重点关注银屑病与新型冠状病毒肺炎的相互影响以及疫情带来的特殊挑战
Clin Case Rep. 2022 Apr 20;10(4):e05722. doi: 10.1002/ccr3.5722. eCollection 2022 Apr.
4
Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19.血清尿酸、前白蛋白水平、乳酸脱氢酶与新型冠状病毒肺炎严重程度的相关性分析
Front Mol Biosci. 2021 Jul 12;8:615837. doi: 10.3389/fmolb.2021.615837. eCollection 2021.
5
The signal pathways and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的信号通路与治疗策略。
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0.
6
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.接受系统治疗的中度至重度斑块状银屑病患者感染新冠疫情的风险
Vaccines (Basel). 2020 Dec 2;8(4):728. doi: 10.3390/vaccines8040728.
7
Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23.一名正在接受白细胞介素23抑制剂瑞莎珠单抗治疗的患者出现无症状的严重急性呼吸综合征冠状病毒2感染。
JAAD Case Rep. 2021 Jan;7:60-61. doi: 10.1016/j.jdcr.2020.10.032. Epub 2020 Nov 6.

本文引用的文献

1
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病（COVID-19）相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
2
Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.4例接受生物制剂治疗的银屑病患者的新型冠状病毒肺炎感染演变情况
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e360-e361. doi: 10.1111/jdv.16587. Epub 2020 Jun 8.
3
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.2019年冠状病毒病大流行对接受生物疗法治疗的慢性斑块状银屑病患者的影响：意大利北部的经验。
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
4
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.一名接受白细胞介素-23抑制剂治疗的银屑病患者感染了新型冠状病毒。
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e254-e255. doi: 10.1111/jdv.16468. Epub 2020 Jun 10.
5
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.管理 COVID-19 大流行期间的皮肤免疫介导性疾病。
Am J Clin Dermatol. 2020 Jun;21(3):307-311. doi: 10.1007/s40257-020-00514-2.
6
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征：回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
7
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.